The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
950
June 9, 1995
View Complete Issue         Table of Contents 2019 
Estrogen-Progestin Combinations for Postmenopausal Use
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Estrogen-Progestin Combinations for Postmenopausal Use
June 9, 1995 (Issue: 950)
Two products combining conjugated estrogens with medroxyprogesterone acetate (Prempro and - Wyeth-Ayerst) were recently approved for marketing by the US Food and Drug Administration. Both combine in one package tablets of Premarin, a conjugated...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Estrogen-Progestin Combinations for Postmenopausal Use
Article code: 950c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.